Comparing the current results to its competitors, Hologic Inc reported Revenue increase in the 1 quarter 2025 by 44.84 % year on year. The sales growth was above Hologic Inc's competitors' average revenue growth of 4.64 %, achieved in the same quarter.
Hologic Inc Net Income in the 1 quarter 2025 fell year on year by -10.9%, while most of its competitors have experienced a contraction in net income by -46.71 %.
Strong sales growth of 44.84 % in Overall company contributed to Hologic Inc increase in total revenue by 44.84 % Hologic Inc improved its market share in this segment, to approximately 1.43 %.
Zynex Inc's business model revolves around the development and distribution of medical devices and software that provide non-invasive electrotherapy for pain management and rehabilitation.
Koninklijke Philips Nv operates as a diversified technology company, focusing on areas such as healthcare, consumer lifestyle, and lighting. The company provides a wide range of products and solutions, including medical imaging equipment, home appliances, personal care products, and lighting solutions. Philips Nv's business model involves innovation-driven research and development, strategic partnerships, and a global distribution network to deliver its products and services to customers worldwide.
Orasure Technologies Inc's business model revolves around the development, manufacturing, and distribution of innovative diagnostic products, primarily in the field of oral fluid diagnostics.
Nano X Imaging Ltd is a medical imaging technology company that aims to revolutionize the field by developing and commercializing a novel digital X-ray system. Their business model involves building partnerships with healthcare providers, imaging equipment manufacturers, and distributors to bring their innovative technology to market, providing cost-effective and accessible diagnostic solutions globally. By delivering high-quality imaging at a fraction of the cost of traditional systems, Nano X Imaging aims to improve healthcare outcomes and increase patient access to effective diagnostics.
Sources:
Hologic Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Hologic Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
